1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Patient clinical characteristics and demographics (N = 17)
Demographics and Characteristics 
Age (yr)^{^a} 55.7 (12.3)
Men 64.7%
Race (white/African American) 12/5
Lesion side (right) 70.6%
Stroke etiology 
    Small-vessel disease 35.3%
    Cardioembolism 17.6%
    Large-vessel atherosclerosis 29.4%
    Unknown 17.6%
rtPA or reperfusion therapy 41.2%
Hypertension 82.4%
Diabetes mellitus 35.3%
Dyslipidemia 70.6%
Atrial fibrillation 23.5%
Coronary artery disease 11.8%
Antiplatelet use 88.2%
Anticoagulation use 17.6%
Statin on discharge 82.3%
Smoking on admission 47.1%
Length of hospital stay (days)^{^a} 5.8 (3.8)
Clinical assessment 
    Days between stroke onset and MRI^{^a} 2.0 (1.0)
    Days from stroke onset to baseline assessment^{^a} 2.6 (1.5)
    Days from admission to follow-up visit^{^a} 94.1 (9.6)
    Median No. of days of rehabilitation therapy 34 (18.1)
    Baseline NIHSS score^{^a} 11.2 (6.5)
    3-mo NIHSS score^{^a} 4.9 (3.9)
    Baseline FM-UE scale^{^a} 19.1 (16.9)
    3-month FM-UE scale^{^a} 29.1 (22.0)
    Median 3-mo mRS (range) 3 (1–4)
Location of infarction (No.) (%) 
    Right hemisphere 12 (70.5)
    Left hemisphere 5 (29.5)
    Motor cortex 6 (35.3)
    Premotor cortex 5 (29.5)
    Centrum semiovale 4 (23.5)
    Corona radiata 9 (52.9)
    Posterior limb of the internal capsule 9 (52.9)
    Brain stem 4 (23.5)
↵a Mean (SD).